Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+25.4%
5Y CAGR+161.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+25.4%/yr
Annual compound
5Y CAGR
+161.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
122.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $172.92M | +51.6% |
| 2024 | $114.09M | +131.4% |
| 2023 | $49.30M | -43.8% |
| 2022 | $87.70M | +726.4% |
| 2021 | $10.61M | +653.2% |
| 2020 | $1.41M | - |